Inceptua Early Access and Sentynl Therapeutics, a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases have entered into a partnership to make Sentynl’s Nulibry available via an Early Access Program for eligible patients with molyb- denum cofactor deficiency (MoCD) Type A.
Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly and is now valued at US$7.8 billion with a projected growth of 14% per annum [1]. Cambridge Cognition is an active player in the central nervous system (CNS) market, supplying digital solutions to assess brain health. Now, in a major strategic move […]
Becton, Dickinson and Company (BD), a leading global medical technology company, and Biocorp, a medical device and delivery systems manufacturer based in France, have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics.
An Extraordinary General Meeting of Shareholders (EGM) of Royal Philips appointed Roy Jakobs as the company’s next president and Chief Executive Officer, effective October 15, 2022, succeeding current president and CEO Frans van Houten.
Press Release November 2022 Global market leader in next-generation auto-ID and labelling solutions, SATO has partnered with Swiss-based identification technology pioneers, Solid Solutions en Identification SA (‘Solid’), to enable MV Santé to monitor patients in its wards using SATO’s RAIN RFID wristband.
New facility supports customers and employees in the APAC region with leading-edge technology
The International Hospital Federation (IHF) announced the shortlist of finalists of the IHF Awards 2022 in seven categories. This year, more than 400 entries were submitted from 35 countries and territories – a record since the Awards were established in 2015.
The 35th National Healthcare CFO Summit travels to Boston!
Bio-Gate AG, a medical technology company that develops applications which use unique silver technology to help prevent infections, has concluded a contract with a leading multinational medical device manufacturer for the antimicrobial coating of orthopaedic implants in human medicine. As part of the cooperation and the joint project management, Bio-Gate is responsible for the application […]
In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
